Acurian

What Acurian does

Acurian is a privately-held clinical trial patient recruitment company founded in 1998 and headquartered in Horsham, Pennsylvania. According to firmographic data, the company's core function is recruiting patients and physicians for participation in clinical drug trials, operating with a workforce of 51-100 employees. The business serves pharmaceutical sponsors and contract research organizations (CROs) that require patient identification, engagement, and pre-screening services across a range of therapy areas including biosimilars, cardiovascular, dermatology, metabolic, neurology, respiratory, vaccines, and early-phase clinical trials.

The company's service offering encompasses patient identification and engagement, pre-screening, integrated site services, and home-based trial visit options. Distribution relies on direct enterprise sales engagement with sponsors and CROs, supported by a proprietary patient database used to match trial protocols with eligible participants. The patient recruitment value chain spans marketing to potential participants, screening for protocol eligibility, and retention through trial completion. Marketing channels include organic search, content marketing via insights/blog resources, and LinkedIn professional engagement targeting the sponsor and CRO buyer audience.

Acurian has raised approximately $43.4M across disclosed funding rounds spanning 1998 through 2017, with strategic pharmaceutical participation including Merck Capital Ventures across multiple rounds and EuclidSR Partners as lead in the 2001 round. The company maintains a private structure with Leslie Michelson as Chief Executive Officer and Scott Ballenger as Vice President of Business Development. Detailed pricing models, revenue figures, and named customer relationships are not publicly disclosed in the input data.

Name

Acurian

Legal name

Trialmed

Website

https://acurian.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

51–100 employees

Short description

Acurian is a privately-held clinical trial patient recruitment company founded in 1998 that connects pharmaceutical sponsors and CROs with patients and physicians for participation in clinical drug trials across multiple therapy areas.

Ownership category

akta.pro rank

Product category

Clinical Trial Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Clinical trial recruitment
• Patient recruitment services
• Clinical trial site services
• Patient identification platform
• Clinical research services

Headquarters

HQ city

Horsham

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical trial site services: Trialmed operates a network of 250+ high-performing clinical trial sites and provides integrated site services including patient identification, engagement, pre-screening, and site management. Revenue is generated through study fees charged to pharmaceutical sponsors and CROs for patient recruitment, site access, and trial management services.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Acurian (operating as Trialmed) recruits patients and physicians for participation in clinical drug trials and delivers integrated clinical trial site services to pharmaceutical sponsors and CROs. The company operates a network of 250+ owned clinical trial sites across the US, UK, Czech Republic, and Poland, supported by a 20M+ identified patient database, and provides patient identification, engagement, pre-screening, site management, and home/remote trial visit services across multiple therapy areas.

Product overview

No Acurian-specific product information is available in the provided source data. The source data describes Trialmed, a separate clinical trials and research company offering patient recruitment, site services, and clinical trial management solutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Integrated Clinical Trial Site Services
• Patient Identification and Engagement
• Pre-Screening Services
• Home Trial Services
• Early Phase Clinical Trials
• Therapy Area Specialist Trials
• Patient Study Finder Portal

Quantifiable outcome

• 250+ high-performing sites
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• Velocity Clinical Research: A dedicated site management organization (SMO) operating a large network of owned and integrated clinical trial sites across the US. Directly comparable to Trialmed's 250+ site network and integrated site services model.
• CenExel: A clinical research site network with therapeutic-area expertise (including early phase and CNS) and embedded patient recruitment capabilities. Comparable in business model as a focused SMO with patient recruitment built into site operations.
• Medpace: A mid-size full-service CRO with strong site management and patient recruitment capabilities across multiple therapy areas. Directly comparable to Trialmed as a CRO with site services and recruitment focus.

Broad incumbents

• ICON plc: A global full-service CRO that acquired PRA Health Sciences, offering broad clinical operations, site services, and patient recruitment. Comparable in customer base (pharma sponsors) and broad therapy-area coverage.
• IQVIA: The world's largest CRO with extensive site network, real-world data assets, and patient recruitment technology. Competes with Trialmed for the same pharmaceutical sponsor and CRO customers on a global scale.
• Syneos Health: A global biopharmaceutical solutions organization (now privately held) offering clinical development and commercialization services, including site management and patient recruitment. Comparable in serving the same sponsor base with full-service capabilities.
• PPD (Pharmaceutical Product Development): A global CRO now part of Thermo Fisher Scientific (the same parent as Trialmed), with extensive site and patient recruitment capabilities. Comparable as a sibling entity serving the same end markets through the same parent platform.
• Parexel: A global clinical research and biopharmaceutical services provider offering site management, patient recruitment, and full-service clinical operations. Comparable in sponsor customer base and global delivery model.

Emerging players

• Science 37: A decentralized clinical trial platform that enables remote and home-based patient participation. Comparable to Trialmed's home trial services offering and emerging as a recruitment and participation disruptor.
• Deep 6 AI: An AI-driven patient recruitment platform that mines structured and unstructured EHR data to find trial candidates. Comparable to Trialmed's recruitment business and a leading technology-enabled disruptor to legacy recruitment approaches.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/acurian
• Xx.com/acuriancarest2d

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Acurian